Vitrectomy Status Alters Early Intravitreal Drug Distribution: An Ex Vivo PET-CT Study
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.8.36 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Sabrina Wohlfart and 9 co-authors. Institution: The David J Apple Laboratory for Vision Research, University Eye Clinic Heidelberg, Heidelberg Germany. Major MEDLINE topics: Bevacizumab, Vitreous Body, Vancomycin, Vitrectomy. Cited 1 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
We aimed to evaluate the ex-vivo early-phase spatial drug distribution of intravitreally applied bevacizumab and vancomycin in human and porcine eyes with a native vitreous body compared to vitrectomized eyes filled with balanced salt solution (BSS), silicone oils and a hyaluronic acid-based vitreous body substitute hydrogel.
Methods
Porcine eyes were vitrectomized minutes post-mortem and filled with BSS, silicone oil, or hydrogel. Native non-vitrectomized human and porcine eyes served as controls. Intravitreal injections consisted of either bevacizumab or vancomycin labeled with Gallium-68 (68-Ga). Positron emission computer tomography (PET-CT) imaging of cadaver eyes was performed for up to six hours after injection followed by qualitative depiction and quantification of intravitreal distribution of the labeled drugs.
Results
Radioactive labeling with 68-Ga and subsequent purification of bevacizumab and vancomycin was successfully applied. Vitrectomized eyes presented an increased early spatial spread of both tested drugs compared to native vitreous body (intravitreal bevacizumab filled volume 36.5% vs. 16.5% [P < 0.0001], intravitreal vancomycin filled volume 31.8% vs. 12.0% [P = 0.0146] after injection). Bevacizumab tended to show a faster diffusion in native vitreous body compared to vancomycin. Bevacizumab appeared not to be soluble in silicone oil. Diffusion within a vitreous body replacement hydrogel is slower compared to BSS-filled eyes in the early phase.
Conclusions
Ophthalmic surgical interventions and used endotamponades have a significant impact on early phase spatial diffusion within the vitreous cavity. Based on these preliminary results, early phase diffusion of protein drugs within a hyaluronic acid-based hydrogel is comparable to the native vitreous body.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- The David J Apple Laboratory for Vision Research, University Eye Clinic Heidelberg, Heidelberg Germany.
- Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany.
- Institue of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.
Cite
APA
Wohlfart, S., Roettgen, H. G., Junker, N., Augustin, V. A., Ackermann, B. C., Geisweid, L., Auffarth, G. U., Mier, W., Uhl, P., & Hammer, M. (2026). Vitrectomy Status Alters Early Intravitreal Drug Distribution: An Ex Vivo PET-CT Study. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.8.36
Vancouver
Wohlfart S, Roettgen HG, Junker N, Augustin VA, Ackermann BC, Geisweid L, et al. Vitrectomy Status Alters Early Intravitreal Drug Distribution: An Ex Vivo PET-CT Study. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.8.36
BibTeX
@article{Wohlfart2026,
author = {Wohlfart, Sabrina and Roettgen, Hellen Gertrud and Junker, Niklas and Augustin, Victor Aristide and Ackermann, Bryan Calder and Geisweid, Ludwig and Auffarth, Gerd Uwe and Mier, Walter and Uhl, Philipp and Hammer, Maximilian},
title = {Vitrectomy Status Alters Early Intravitreal Drug Distribution: An Ex Vivo PET-CT Study},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.8.36}
}
EUVIMED